Search Results - "Béjaud, J"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring by Lainé, A-L, Gravier, J, Henry, M, Sancey, L, Béjaud, J, Pancani, E, Wiber, M, Texier, I, Coll, J-L, Benoit, J-P, Passirani, C

    Published in Journal of controlled release (28-08-2014)
    “…The determination of the nanocarrier fate in preclinical models is required before any translation from laboratory to clinical trials. Modern fluorescent…”
    Get full text
    Journal Article
  2. 2

    Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133 by Bourseau-Guilmain, E., Béjaud, J., Griveau, A., Lautram, N., Hindré, F., Weyland, M., Benoit, J.P., Garcion, E.

    Published in International journal of pharmaceutics (14-02-2012)
    “…In the context of targeted therapy, we addressed the possibility of developing a drug delivery nanocarrier capable to specifically reach cancer cells that…”
    Get full text
    Journal Article
  3. 3

    Silencing of miR-21 by locked nucleic acid–lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death by Griveau, A., Bejaud, J., Anthiya, S., Avril, S., Autret, D., Garcion, E.

    Published in International journal of pharmaceutics (01-10-2013)
    “…The recent discovery of microRNA (miRNA) as major post-transcriptional repressors prompt the interest of developing novel approaches to target miRNA pathways…”
    Get full text
    Journal Article
  4. 4

    Demonstration of the interactions between aromatic compound-loaded lipid nanocapsules and Acinetobacter baumannii bacterial membrane by Montagu, A., Joly-Guillou, M-L., Guillet, C., Bejaud, J., Rossines, E., Saulnier, P.

    Published in International journal of pharmaceutics (15-06-2016)
    “…[Display omitted] Acinetobacter baumannii is an important nosocomial pathogen that is resistant to many commonly-used antibiotics. One strategy for treatment…”
    Get full text
    Journal Article
  5. 5

    Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells by Weyland, M., Griveau, A., Bejaud, J., Benoit, J-P., Coursaget, P., Garcion, E.

    Published in International journal of pharmaceutics (01-10-2013)
    “…Plasmid DNA (pDNA) and small interfering RNAs (siRNAs) are very useful tools for the treatment of cancer. However, pDNA and siRNAs efficacy is restricted by…”
    Get full text
    Journal Article
  6. 6

    Silencing of miR-21 by locked nucleic acidalipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death by Griveau, A, Bejaud, J, Anthiya, S, Avril, S, Autret, D, Garcion, E

    Published in International journal of pharmaceutics (01-10-2013)
    “…The recent discovery of microRNA (miRNA) as major post-transcriptional repressors prompt the interest of developing novel approaches to target miRNA pathways…”
    Get full text
    Journal Article